Navigation Links
Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013
Date:6/21/2013

n the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the Company's newly-acquired To Go Brands® nutraceutical business. The Company's lead commercial product, Excellagen® topical gel for wound care management, has received FDA clearance for marketing and sale in the United States.  Cardium's lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. To Go Brands® develops, markets and sells dietary supplements through established regional and national retailers.  In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. For more information, visit www.cardiumthx.com.

Forward-Looking Statements  

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from expectations. For example, there is no assurance that the company will obtain sufficient additional votes in connection with the adjourned meeting or that the remaining proposals will be approved at the reconvened meeting or at any subsequent meeting, that planned product development efforts and clinical studies can be performed in an efficient and effective manner; that results or trends observed in one clinical study or procedure will be reproduced
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan
2. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
3. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
4. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
5. Cardium to Present at Upcoming Investor Conferences
6. China Green Agriculture Inc. Announces Ministry of Agriculture Engaged Gufeng as Corporate Participant in the Ministrys Fertilizer Promotion Program
7. Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System
8. Techne Corporation Announces Acquisition Agreement
9. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
10. Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions
11. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... CA (PRWEB) , ... September ... ... announced the launch of the new ImageXpress® Micro Confocal High-Content Imaging System. ... especially emerging assays that use 3D cellular models such as spheroids, tissues, ...
(Date:9/1/2015)... ... 01, 2015 , ... Leading CEOs, CSOs, CMOs, and heads ... join prominent academics and key investors for Neuro Advance Boston, October 14, 2015 ... , Neuro Advance Boston focuses on the latest developments and opportunities in ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... University of California Los Angeles, Boston University School of Medicine, Frederick National Laboratory ... PLOS One, the world’s first multidisciplinary Open Access journal. , Christopher Ryan ...
(Date:8/31/2015)... Pune (PRWEB) , ... August 31, 2015 , ... ... in various industries because of its properties such as low carbon footprints and ... by the use of petroleum based plastics. On the basis of applications, the ...
Breaking Biology Technology:ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 4Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 5
... The p Silencer 5.1 ... researchers to study the long-term effects of reducing , ... retroviral vectors make use of H1 or U6 Polymerase ... stably express siRNAs, even in , ...
... mirVana PARIS Kit--Optimized for Recovery of siRNA and miRNA , ... , Small RNA, mRNA, and Protein , ... from both the <A , ... href="http://www.ambion.com/catalog/CatNum.php?">Vana , miRNA Isolation Kit , optimized for small ...
... Patricia Powers & Emmanuel , ... Quantitative recovery of small RNA , ... requires optimized RNA isolation procedures [1]. The <A , ... miRNA Isolation Kit is the first commercially available , ...
Cached Biology Technology:Enhanced siRNA Delivery and Long-term Gene Silencing 2Enhanced siRNA Delivery and Long-term Gene Silencing 3Enhanced siRNA Delivery and Long-term Gene Silencing 4Enhanced siRNA Delivery and Long-term Gene Silencing 5Enhanced siRNA Delivery and Long-term Gene Silencing 6Enhanced siRNA Delivery and Long-term Gene Silencing 7Enhanced siRNA Delivery and Long-term Gene Silencing 8Enhanced siRNA Delivery and Long-term Gene Silencing 9Enhanced siRNA Delivery and Long-term Gene Silencing 10Isolate Total RNA and Protein From the Same Sample 2Isolate Total RNA and Protein From the Same Sample 3Isolate Total RNA and Protein From the Same Sample 4Isolate Total RNA and Protein From the Same Sample 5Get the miRNA OutPlant Applications 2Get the miRNA OutPlant Applications 3Get the miRNA OutPlant Applications 4Get the miRNA OutPlant Applications 5Get the miRNA OutPlant Applications 6Get the miRNA OutPlant Applications 7
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Saudi Arabia Biomedical Sensors Market - ... offering. The Saudi Arabia Biomedical Sensors ... a CAGR of 3.64% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/24/2015)... Aug. 24, 2015  Based on its recent analysis of ... the 2015 African Biometrics Company of the Year Award. DERMALOG ... commercial success in Africa . It has ... it has implemented one of the largest biometric mass applications ... as the Central Bank of Nigeria ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... Nguyen has been elected as a fellow of ... the national organization,s Council on Basic Cardiovascular Sciences., ... Arlington in 2005, specializes in cellular engineering. Her ... stem cell therapies., Liping Tang, interim chairman of ...
... (Nov. 20, 2013) - When invasive species move into new ... that make them sick. But new research from evolutionary biologists ... in the immune system may help house sparrows, one of ... In research published this week in Proceedings of the ...
... Bone grafts, which are used to treat head injuries ... scientists are reporting progress toward a new hormone therapy ... study, which was conducted on mice, appears in the ... Gazit at Cedars-Sinai Medical Center, Edward Schwarz from Rochester ...
Cached Biology News:USF researchers show invasive sparrows immune cells sharpen as they spread 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Biology Products: